CRISPR QC Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

CRISPR QC General Information

Description

Developer of an analytics platform designed to simulate the gene editing process before introduction to cells. The company's platform provides key cornerstones of information and insight fundamental to realizing the full potential and quality control for clustered regularly interspaced short palindromic repeats gene editing, enabling scientists to increase editing efficiency and define a strategy to achieve better outcomes at the cellular level.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6191 Cornerstone Court E
  • Suite 113
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 6191 Cornerstone Court E
  • Suite 113
  • San Diego, CA 92121
  • United States
+1 (858)

CRISPR QC Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CRISPR QC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Early Stage VC (Series A1) 02-Apr-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
3. Seed Round 11-Jan-2023 Completed Generating Revenue
2. Accelerator/Incubator 16-Aug-2022 Completed Generating Revenue
1. Accelerator/Incubator 05-Apr-2022 Completed Generating Revenue
To view CRISPR QC’s complete valuation and funding history, request access »

CRISPR QC Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-2
Seed 2,283,892 $0.000100 $0.71 $0.71 1x $0.71 10.36%
To view CRISPR QC’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CRISPR QC Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CRISPR QC Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biobrit Venture Capital Minority
Keiretsu Forum Angel Group Minority
Suncoast Ventures Venture Capital Minority
Xcellerant Ventures Venture Capital Minority
BioTools Innovator Accelerator/Incubator Minority
You’re viewing 5 of 10 investors. Get the full list »

CRISPR QC FAQs

  • When was CRISPR QC founded?

    CRISPR QC was founded in 2021.

  • Where is CRISPR QC headquartered?

    CRISPR QC is headquartered in San Diego, CA.

  • What is the size of CRISPR QC?

    CRISPR QC has 12 total employees.

  • What industry is CRISPR QC in?

    CRISPR QC’s primary industry is Other Healthcare Technology Systems.

  • Is CRISPR QC a private or public company?

    CRISPR QC is a Private company.

  • What is CRISPR QC’s current revenue?

    The current revenue for CRISPR QC is .

  • How much funding has CRISPR QC raised over time?

    CRISPR QC has raised $11.6M.

  • Who are CRISPR QC’s investors?

    Biobrit, Keiretsu Forum, Suncoast Ventures, Xcellerant Ventures, and BioTools Innovator are 5 of 10 investors who have invested in CRISPR QC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process